Risks and benefits of using antiretroviral therapy in HIV-infected patients with chronic hepatitis B in developing regions

Clin Infect Dis. 2008 Dec 1;47(11):1486-9. doi: 10.1086/593105.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Retroviral Agents / adverse effects
  • Anti-Retroviral Agents / therapeutic use*
  • Antiretroviral Therapy, Highly Active*
  • Developing Countries
  • Female
  • HIV Infections / complications*
  • HIV Infections / drug therapy*
  • HIV Infections / mortality
  • Hepatitis B, Chronic / epidemiology*
  • Humans
  • Male
  • Treatment Outcome

Substances

  • Anti-Retroviral Agents